Acclarent

Acclarent

Medical Device

Irvine, CA 12,753 followers

About us

Acclarent, Inc., part of Integra LifeSciences, is a medical device company in Irvine, CA that was established in June of 2004. We’re dedicated to supporting Ear, Nose, and Throat (ENT) surgeons with minimally invasive technologies designed to preserve nasal anatomy, while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction. Commercially launched in 2005, our Balloon Sinuplasty technology has been used by otolaryngologists in over 535,000 procedures. ©Acclarent, Inc. 2022

Industry
Medical Device
Company size
201-500 employees
Headquarters
Irvine, CA
Type
Public Company
Specialties
Ear, Nose, Throat, Medical Device, Sinus, Balloon Sinuplasty, Navigation, and ETBD

Locations

Employees at Acclarent

Updates

  • View organization page for Acclarent, graphic

    12,753 followers

    How ACCLARENT AERA® Eustachian Tube Balloon dilation works?  - Mechanism of action (1) Pathology lies within the cartilaginous segment of the Eustachian tube Histopathology research has demonstrated that balloon dilation may: -Shear or crush portions of the epithelium; usually sparing the basal layer and allowing for rapid healing -Crush lymphocytes and lymphoid follicle -Combined, these effects reduce overall inflammatory burden and may be the underlying reason for lasting clinical improvement in Eustachian tube dilation and ventilation - Indications: The ACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended to dilate the Eustachian tube for treatment of persistent Eustachian tube dysfunction in patients ages 18 and older. For patients ages 8-17 years, The ACCLARENT AERA Eustachian Tube Dilatation System, alone or in combination with adjunctive procedures, is intended to treat patients with objective signs of persistent obstructive Eustachian tube dysfunction from inflammatory pathology, resulting in chronic otitis media with effusion and are refractory to at least one surgical intervention for persistent obstructive Eustachian tube dysfunction. 1-Kivekäs I, Chao WC, Faquin W, et al. Histopathology of balloon-dilation Eustachian tuboplasty. Laryngoscope. 2015 Feb;125(2):436-441 2-Traditional 510(k): Device Labeling Modification to ACCLARENT AERA(R) Eustachian Tube Balloon System, (K230742), dated December 13, 2023. #acclarent #ACCLARENTAERA

  • View organization page for Acclarent, graphic

    12,753 followers

    REIMAGINE NAVIGATION with TruDi® Navigation System: Submillimeter Accuracy(1) – Real time feedback(2) and constant advancements. 1. Allen DZ, Talmadge J, Citardi MJ. Semi-Quantitative Assessment of Surgical Navigation Accuracy During Endoscopic Sinus Surgery in a Real-World Environment. Ann Otol Rhinol Laryngol. 2024 Oct 1:34894241286982. 2. TruDi® Navigation System Instructions for Use. UG-2000-0023 (04A), 2024. #acclarent  #TruDi

    • No alternative text description for this image
  • Acclarent reposted this

    View organization page for Acclarent, graphic

    12,753 followers

    In-office balloon sinus dilation procedures eliminate the risks associated with general anesthesia performed in the hospital. It can present considerable cost-saving potential when compared to traditional sinus procedures performed in a hospital. Michael Freedman, MD, explains how balloon sinuplasty can treat sinusitis in a minimally invasive way.  Learn more: https://lnkd.in/gjmzKdgs #Acclarent #BalloonSinuplasty #BSP #ENT

Similar pages

Browse jobs

Funding

Acclarent 4 total rounds

Last Round

Series unknown

US$ 26.0M

See more info on crunchbase